Nova EYE Medical Ltd - Asset Resilience Ratio

Latest as of December 2025: 11.08%

Nova EYE Medical Ltd (EYE) has an Asset Resilience Ratio of 11.08% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check EYE strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

AU$2.62 Million
≈ $1.86 Million USD Cash + Short-term Investments

Total Assets

AU$23.67 Million
≈ $16.75 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2001–2025)

This chart shows how Nova EYE Medical Ltd's Asset Resilience Ratio has changed over time. See EYE equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Nova EYE Medical Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Nova EYE Medical Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$2.62 Million 11.08%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$2.62 Million 11.08%

Asset Resilience Insights

  • Moderate Liquidity: Nova EYE Medical Ltd has 11.08% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Nova EYE Medical Ltd Industry Peers by Asset Resilience Ratio

Compare Nova EYE Medical Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Inspire Medical Systems Inc
NYSE:INSP
Medical Devices 20.29%
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
Medical Devices 0.84%
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
Medical Devices 19.31%
Stratec SE
XETRA:SBS
Medical Devices 0.30%
Duearity AB
ST:DEAR
Medical Devices 145.62%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%

Annual Asset Resilience Ratio for Nova EYE Medical Ltd (2001–2025)

The table below shows the annual Asset Resilience Ratio data for Nova EYE Medical Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-06-30 19.07% AU$5.05 Million
≈ $3.58 Million
AU$26.50 Million
≈ $18.75 Million
-1.51pp
2024-06-30 20.58% AU$6.15 Million
≈ $4.35 Million
AU$29.88 Million
≈ $21.14 Million
-3.85pp
2023-06-30 24.44% AU$7.42 Million
≈ $5.25 Million
AU$30.36 Million
≈ $21.48 Million
+2.60pp
2022-06-30 21.84% AU$8.00 Million
≈ $5.66 Million
AU$36.62 Million
≈ $25.91 Million
-20.55pp
2021-06-30 42.39% AU$17.80 Million
≈ $12.60 Million
AU$41.99 Million
≈ $29.71 Million
-39.54pp
2020-06-30 81.93% AU$95.65 Million
≈ $67.68 Million
AU$116.74 Million
≈ $82.60 Million
+66.54pp
2019-06-30 15.39% AU$15.37 Million
≈ $10.88 Million
AU$99.89 Million
≈ $70.68 Million
-6.91pp
2018-06-30 22.29% AU$23.07 Million
≈ $16.32 Million
AU$103.47 Million
≈ $73.21 Million
+11.61pp
2017-06-30 10.68% AU$9.24 Million
≈ $6.54 Million
AU$86.54 Million
≈ $61.23 Million
+10.30pp
2008-06-30 0.38% AU$275.00K
≈ $194.58K
AU$71.94 Million
≈ $50.90 Million
+0.12pp
2007-06-30 0.26% AU$167.00K
≈ $118.16K
AU$63.69 Million
≈ $45.06 Million
+0.16pp
2006-06-30 0.10% AU$46.00K
≈ $32.55K
AU$46.48 Million
≈ $32.88 Million
-42.45pp
2001-06-30 42.54% AU$487.42K
≈ $344.88K
AU$1.15 Million
≈ $810.63K
--
pp = percentage points

About Nova EYE Medical Ltd

AU:EYE Australia Medical Devices
Market Cap
$22.17 Million
AU$31.34 Million AUD
Market Cap Rank
#24789 Global
#1018 in Australia
Share Price
AU$0.11
Change (1 day)
-4.35%
52-Week Range
AU$0.10 - AU$0.20
All Time High
AU$0.46
About

Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It also engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser; 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degen… Read more